{
    "organizations": [],
    "uuid": "a65f7611c024852ac281d1f8077e5bbbb9929a6b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-loxo-oncology-reports-quarterly-no/brief-loxo-oncology-reports-quarterly-non-gaap-net-loss-per-share-1-24-idUSASB0C88M",
    "ord_in_thread": 0,
    "title": "Loxo Oncology Reports Quarterly Non-Gaap Net Loss Per Share $1.24",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 1 (Reuters) - Loxo Oncology Inc:\n* LOXO ONCOLOGY REPORTS FOURTH QUARTER AND YEAR-END 2017 FINANCIAL RESULTS\n* ‍LAROTRECTINIB ROLLING NDA SUBMISSION ON TRACK FOR COMPLETION IN MARCH​\n* ‍LOXO-292 PHASE 1 CLINICAL DATA UPDATE EXPECTED IN FIRST HALF 2018​\n* ‍ REVENUE FROM COLLABORATION AGREEMENT WAS $21.3 MILLION FOR Q4 COMPARED TO NONE FOR Q4 2016​\n* INITIATION OF PHASE 1 CLINICAL TRIAL FOR LOXO-305 (BTK) IS EXPECTED IN SECOND HALF OF 2018\n* QTRLY NET LOSS PER SHARE OF COMMON STOCK, BASIC AND DILUTED $0.69‍​\n* QUARTERLY NON-GAAP NET LOSS PER SHARE $1.24\n* Q4 EARNINGS PER SHARE VIEW $-1.13 — THOMSON REUTERS I/B/E/S Source text for Eikon: (Reuters.Brief@thomsonreuters.com)\n ",
    "published": "2018-03-01T19:48:00.000+02:00",
    "crawled": "2018-03-02T19:49:38.016+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "loxo",
        "oncology",
        "inc",
        "loxo",
        "oncology",
        "report",
        "fourth",
        "quarter",
        "financial",
        "result",
        "rolling",
        "nda",
        "submission",
        "track",
        "completion",
        "phase",
        "clinical",
        "data",
        "update",
        "expected",
        "first",
        "half",
        "revenue",
        "collaboration",
        "agreement",
        "million",
        "q4",
        "compared",
        "none",
        "q4",
        "initiation",
        "phase",
        "clinical",
        "trial",
        "btk",
        "expected",
        "second",
        "half",
        "qtrly",
        "net",
        "loss",
        "per",
        "share",
        "common",
        "stock",
        "basic",
        "diluted",
        "quarterly",
        "net",
        "loss",
        "per",
        "share",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon"
    ]
}